top of page
rhinitis, medicine and healthcare concept - close up of sick woman using nasal spray.jpg


Our Tinnitus Treatment Solution Through Small Molecule Therapy

GW-TT2 Pipeline

GW-TT2 is a nasal formulation designed to treat moderate to severe tinnitus that has developed within the last two years. (Recent onset tinnitus)

Recent onset tinnitus is the initial indication but expansion into additional indications is likely.

Our tests have shown GW-TT2 to be highly effective in a mouse model of noise-induced tinnitus.

US GW-TT2 Target Population

GW-TT2 Target Population

Our GW-TT2 Development Plan

GW-TT2 Dev Plan
bottom of page